BLACK DIAMOND THERAPEUTICS, INC. Debt Securities, Available-for-sale, Noncurrent
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) had Debt Securities, Available-for-sale, Noncurrent of $140.52 million as of 2020-06-30, per its 10-Q filed 2020-08-11.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent · last filed 2020-08-11
- 2020-06-30: Debt Securities, Available-for-sale, Noncurrent $140.52M.
- 2019-12-31: Debt Securities, Available-for-sale, Noncurrent $0.00.
| Period end | Debt Securities, Available-for-sale, Noncurrent |
|---|---|
| 2020-06-30 | $140.52M 10-Q · filed 2020-08-11 |
| 2019-12-31 | $0.00 10-Q · filed 2020-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |